Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Forbion: Dirk Kersten Now Managing Partner; US Expansion (2025-01-13)
> Dirk Kersten promoted to Managing Partner, further strengthening firm’s leadership > Jonathan McNeill, M.D. joins Forbion as Partner in the Boston office Forbion, a leading global life sciences venture capital firm with expertise in Europe, is delighted...
BioLizard Welcomes Arjan van Manen as Commercial Director (2025-01-09)
> Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences > Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biotech Showcase during JP Morgan Week (Jan 13-15, 2025) in San ...
Numab Therapeutics Closes CHF50m Series C Extension (2025-01-09)
> CHF 50 Million extension round co-led by Cormorant Asset Management, with participation from other existing investors > Proceeds will be used to support the advancement of multiple first-in-class and best-in-class programs into clinical development Numa...
Leiden-based Alesta Therapeutics Raises €65m Series A (2025-01-08)
> Oversubscribed Series A financing led by Frazier Life Sciences and Droia Ventures > Lead program, ALE1, being developed in hypophosphatasia with plans to enter clinical development in 2025 > Led by industry veterans and experts in chemistry and rare disease...
Orbis Medicines ApS Raises €90m Series A Led by NEA (2025-01-06)
> Funding to support the development of pipeline of oral macrocycle drugs, called ‘nCycles,’ focused on validated blockbuster biologic targets > Orbis’ nGen platform systematically explores oral macrocycle design with automated chemistry and machine learni...
Merck KGaA to Acquire HUB Organoids for Undisclosed Sum (2024-12-17)
Acquisition to advance company's cell culture portfolio with internationally recognized pioneer in organoid development Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. ...
Gilde HC Invests alongside Capital A in Tromp Medical (2024-12-16)
Tromp Medical, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new investor to drive further growth in the medical imaging market. Headquartered in the Netherlands, Tromp Medical specializes in instal...
VectorY Therapeutics Appoints Jim Scibetta as CEO (2024-12-16)
> Former CEO, Sander van Deventer to become President of R&D > Lead program VTx-002 for Amyotrophic Lateral Sclerosis (ALS) advances into IND-enabling studies following favorable FDA feedback of pre-clinical package > Expansion of corporate footprint into the...
Mainz Biomed Closes $8m Follow-On Offering (2024-12-16)
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previously announced follow-on offering of 1,367,521 units, with eac...
Pharming: Public Cash Offer to Acquire Abliva AB for $66.1m (2024-12-15)
> Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset > Abliva’s lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary ...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)